178 related articles for article (PubMed ID: 16609959)
1. Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression.
Pozzoli G; Tringali G; Vairano M; D'Amico M; Navarra P; Martire M
J Neurosci Res; 2006 May; 83(6):1058-65. PubMed ID: 16609959
[TBL] [Abstract][Full Text] [Related]
2. Role of cannabinoid CB1 receptors and Gi/o protein activation in the modulation of synaptosomal Na+,K+-ATPase activity by WIN55,212-2 and delta(9)-THC.
Araya KA; David Pessoa Mahana C; González LG
Eur J Pharmacol; 2007 Oct; 572(1):32-9. PubMed ID: 17644088
[TBL] [Abstract][Full Text] [Related]
3. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats.
Rahn EJ; Makriyannis A; Hohmann AG
Br J Pharmacol; 2007 Nov; 152(5):765-77. PubMed ID: 17572696
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death.
Chen J; Lee CT; Errico S; Deng X; Cadet JL; Freed WJ
Brain Res Mol Brain Res; 2005 Apr; 134(2):215-25. PubMed ID: 15836919
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor as a novel target for the treatment of prostate cancer.
Sarfaraz S; Afaq F; Adhami VM; Mukhtar H
Cancer Res; 2005 Mar; 65(5):1635-41. PubMed ID: 15753356
[TBL] [Abstract][Full Text] [Related]
6. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
Hoffman AF; Macgill AM; Smith D; Oz M; Lupica CR
Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
[TBL] [Abstract][Full Text] [Related]
7. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats.
Pattij T; Janssen MC; Schepers I; González-Cuevas G; de Vries TJ; Schoffelmeer AN
Psychopharmacology (Berl); 2007 Jul; 193(1):85-96. PubMed ID: 17387457
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes.
Sheng WS; Hu S; Min X; Cabral GA; Lokensgard JR; Peterson PK
Glia; 2005 Jan; 49(2):211-9. PubMed ID: 15390091
[TBL] [Abstract][Full Text] [Related]
9. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.
Blair RE; Deshpande LS; Sombati S; Elphick MR; Martin BR; DeLorenzo RJ
Neuropharmacology; 2009 Sep; 57(3):208-18. PubMed ID: 19540252
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
11. The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells.
Yoshida T; Hashimoto K; Zimmer A; Maejima T; Araishi K; Kano M
J Neurosci; 2002 Mar; 22(5):1690-7. PubMed ID: 11880498
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
[TBL] [Abstract][Full Text] [Related]
13. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins.
Lauckner JE; Hille B; Mackie K
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19144-9. PubMed ID: 16365309
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action.
Köfalvi A; Vizi ES; Ledent C; Sperlágh B
Eur J Neurosci; 2003 Oct; 18(7):1973-8. PubMed ID: 14622229
[TBL] [Abstract][Full Text] [Related]
17. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
19. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2.
Jelsing J; Galzin AM; Guillot E; Pruniaux MP; Larsen PJ; Vrang N
Brain Res Bull; 2009 Mar; 78(4-5):202-10. PubMed ID: 19038314
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]